I still believe at some stage PME will be taken over by one of its competitors in the US medical industry.
In the meantime the company is well run by shareholder focused management with a great product offering.
Ann: PAC Partners Conference Presentation, page-8
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$221.75 |
Change
7.130(3.32%) |
Mkt cap ! $17.90B | |||
| Open | High | Low | Value | Volume |
| $216.99 | $224.65 | $215.12 | $38.21M | 172.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103 | $221.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $221.81 | 426 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| PME (ASX) Chart |
